My Watchlist

Top Indices

Nasdaq Composite

SPX

My Portfolio

Guardant Health, Inc. - Common Stock (NQ:GH)

97.10 -0.37 (-0.38%)

Streaming Delayed Price Updated: 4:00 PM EST, Dec 18, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Guardant Health, Inc. - Common Stock

< Previous 1 2

...

13 14 15 16 17 18 19 20 Next >

Guardant Health and AnHeart Therapeutics Announce Collaboration to Develop Guardant360® CDx and Guardant360 TissueNext™ as Companion Diagnostics for Taletrectinib in Advanced or Metastatic ROS1-Positive Non-Small Cell Lung Cancer

February 02, 2023

From Guardant Health Inc.

Via Business Wire

Magistrate Judge Issues Favorable Recommendation Regarding Guardant Health’s Motion to Dismiss Lawsuit Brought by Illumina

February 02, 2023

From Guardant Health, Inc.

Via Business Wire

Guardant Health to Report Fourth Quarter and Full Year 2022 Financial Results on February 23, 2023

February 01, 2023

From Guardant Health, Inc.

Via Business Wire

Guardant Health introduces Guardant GalaxyTM suite of advanced AI analytics to enhance its portfolio of cancer tests and accelerate biomarker discovery

January 31, 2023

From Guardant Health, Inc.

Via Business Wire

Guardant Health receives FDA approval for Guardant360® CDx as companion diagnostic for Menarini Group’s ORSERDU™ for treatment of patients with ESR1 mutations in ER+, HER2- advanced or metastatic breast cancer

January 30, 2023

From Guardant Health, Inc.

Via Business Wire

Down 40% in 2022, Can Exact Sciences Recover in 2023? ↗

January 23, 2023

Investors are attracted to its leading position in the market for early cancer detection, but the persistent losses its been reporting are enough to make anyone nervous.

Via The Motley Fool

Guardant Health and The Royal Marsden NHS Foundation Trust partner on highly anticipated TRACC Part C trial to use Guardant Reveal™ blood test to help guide treatment decisions in colorectal cancer

January 19, 2023

From Guardant Health, Inc.

Via Business Wire

Guardant Health to showcase new data at ASCO GI 2023 demonstrating utility of its blood tests for patients with gastrointestinal cancers

January 17, 2023

From Guardant Health, Inc.

Via Business Wire

Cathie Wood Makes This Molecular Diagnostics Company Top Holding Of Ark Invest's Flagship Fund, Catapulting Past Zoom, Tesla ↗

January 11, 2023

Shares of Exact Sciences, Inc. (NASDAQ: EXAS) have been on a tear, having gained over 27% in two sessions this week.

Via Benzinga

Guardant Health Announces Preliminary Fourth Quarter and Full Year 2022 Results

January 09, 2023

From Guardant Health, Inc.

Via Business Wire

Guardant Health to Participate in the 41st Annual J.P. Morgan Healthcare Conference

December 28, 2022

From Guardant Health, Inc.

Via Business Wire

Benzinga's Top Ratings Upgrades, Downgrades For January 5, 2023 ↗

January 05, 2023

Via Benzinga

10 Health Care Stocks Whale Activity In Today's Session ↗

December 23, 2022

This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity...

Via Benzinga

Guardant Health and Susan G. Komen® Partner to Develop Clinical Studies to Identify Early-Stage Breast Cancer Patients Who May Benefit From Additional Monitoring or Therapy

December 21, 2022

From Guardant Health, Inc.

Via Business Wire

Barron's Top Weekend Stock Picks: AMD, Ford, Accenture And Should Tesla CEO Elon Musk Be Replaced? ↗

December 17, 2022

Benzinga reviews this weekend's top stories covered by Barron's, here are the articles investors need to read.

Via Benzinga

12 Health Care Stocks Moving In Friday's Intraday Session ↗

December 16, 2022

Via Benzinga

Why Avaya Holdings Shares Are Trading Lower By 62%? Here Are 62 Stocks Moving In Friday's Mid-Day Session ↗

December 16, 2022

Gainers Allarity Therapeutics, Inc. (NASDAQ: ALLR) gained 240% to $0.90. Allarity Therapeutics, last month, posted a Q3 loss of $0.68 per share.

Via Benzinga

This Nasdaq Healthcare Stock's Pain Is Its Rival's Gain ↗

December 16, 2022

The broader market lost more ground on Friday.

Via The Motley Fool

AVYA Stock Alert: Is Avaya Holdings Nearing Bankruptcy? ↗

December 16, 2022

Avaya (AVYA) stock is falling hard on Friday following recent reports that the company is closing in on a bankruptcy filing.

Via InvestorPlace

Why Is Exact Sciences (EXAS) Stock Up 23% Today? ↗

December 16, 2022

Exact Sciences (EXAS) stock is on the rise Friday following news that Guardant Health's (GH) clinical trial didn't go as well as expected.

Via InvestorPlace

Guardant Health (GH) Stock Sinks on Disappointing Blood Test Results ↗

December 16, 2022

Guardant spent more money than it took in while hoping to become a leader in cancer diagnosis, but accuracy remains a problem.

Via InvestorPlace

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

December 16, 2022

Via Benzinga

Why Adobe Shares Are Trading Higher; Here Are 31 Stocks Moving Premarket ↗

December 16, 2022

Gainers Minim, Inc. (NASDAQ: MINM) shares rose 66.5% to $0.2903 in pre-market trading after gaining over 10% on Thursday. Minim, last month, reported worse-than-expected results.

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday ↗

December 16, 2022

We're starting off the final trading day this week with a look at the biggest pre-market stock movers to watch for Friday!

Via InvestorPlace

Guardant Health, Novavax And Some Other Big Stocks Moving Lower In Today's Pre-Market Session ↗

December 16, 2022

U.S. stock futures traded lower this morning. Here are some big stocks recording losses in today’s pre-market trading session.

Via Benzinga

Tesla, Apple, Novavax, Adobe, Guardant Health: Why These 5 Stocks Are Drawing Investors' Attention Today ↗

December 15, 2022

Major Wall Street indices closed over 2% lower on Thursday after U.S. retail sales saw their steepest drop in close to a year last month, suggesting consumers are reining in spending around the...

Via Benzinga

Exact Sciences Rockets As Guardant's Blood Test Pales Vs. Cologuard ↗

December 15, 2022

Exact Sciences' Cologuard has a higher specificity than Guardant's blood test.

Via Investor's Business Daily

After-Hours Action: What's Going On With Guardant Health, Exact Sciences Shares? ↗

December 15, 2022

Guardant Health Inc (NASDAQ: GH) and Exact Sciences Corp (NASDAQ: EXAS) shares are moving in different directions in Thursday's after-hours session. Here's a look at what's going on.

Via Benzinga

12 Health Care Stocks Moving In Thursday's After-Market Session ↗

December 15, 2022

Via Benzinga

Guardant Health announces positive results from pivotal ECLIPSE study evaluating a blood test for the detection of colorectal cancer

December 15, 2022

From Guardant Health, Inc.

Via Business Wire

< Previous 1 2

...

13 14 15 16 17 18 19 20 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.